- Filed
- Jan 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jan 3, 2025 | 30.96M sh |
| Long Term Debt | Q1 2025 · Nov 30, 2024 | $496.3M |
| Long Term Debt | Q1 2025 · Aug 31, 2024 | $496.2M |
| Cash And Equivalents | Q1 2025 · Nov 30, 2024 | $935.6M |
| Cash And Equivalents | Q1 2025 · Aug 31, 2024 | $845.8M |
| Current Liabilities | Q1 2025 · Nov 30, 2024 | $650.6M |
| Current Liabilities | Q1 2025 · Aug 31, 2024 | $687.9M |
| Total Liabilities | Q1 2025 · Nov 30, 2024 | $1.4B |
| Total Liabilities | Q1 2025 · Aug 31, 2024 | $1.44B |
| Current Assets | Q1 2025 · Nov 30, 2024 | $1.94B |
| Current Assets | Q1 2025 · Aug 31, 2024 | $1.87B |
| Total Assets | Q1 2025 · Aug 31, 2024 | $3.81B |
| Shares Diluted | Q1 2025 · Nov 30, 2023 | 31.37M sh |
| Stock Repurchased | Q1 2025 · Nov 30, 2023 | $48.2M |
| Dividends Paid | Q1 2025 · Nov 30, 2023 | $4.1M |
| Capex | Q1 2025 · Nov 30, 2023 | $14.6M |
| Operating Cash Flow | Q1 2025 · Nov 30, 2023 | $190M |
| Stockholders Equity | Q1 2025 · Nov 30, 2023 | $2.06B |
| Stockholders Equity | Q1 2025 · Aug 31, 2023 | $2.02B |
| Eps Diluted | Q1 2025 · Nov 30, 2023 | $3.21 |
| Eps Basic | Q1 2025 · Nov 30, 2023 | $3.25 |
| Sga Expense | Q1 2025 · Nov 30, 2023 | $295.5M |
| Net Income | Q1 2025 · Nov 30, 2023 | $100.6M |
| Operating Income | Q1 2025 · Nov 30, 2023 | $132.9M |
| Gross Profit | Q1 2025 · Nov 30, 2023 | $428.4M |
| Cost Of Revenue | Q1 2025 · Nov 30, 2023 | $506.3M |
| Revenue | Q1 2025 · Nov 30, 2023 | $934.7M |